Shanghai Shentong Metro (600834.SH) plans to transfer 100% equity of Shanghai Metro Financing and Leasing Co., Ltd.
Shentong Subway (600834.SH) announced that, in order to implement the State-owned Assets Supervision and Administration Commission's requirements for deepening the reform of state-owned enterprises and focusing on adjusting their main responsibilities and main businesses, and to optimize the company's asset layout, the company plans to transfer 100% of the equity of its wholly-owned subsidiary, Shanghai Metro Financing Lease Co., Ltd. (referred to as "Financing Lease Company"), to Shanghai Zhangjiang (Group) Co., Ltd. (referred to as "Zhangjiang Group") through an agreement transfer method. The transaction price shall not be less than the audited net assets of the Financing Lease Company as of September 30, 2025, which is 236 million yuan, and shall not be lower than the asset appraisal price approved by the Shanghai Municipal State-owned Assets Supervision and Administration Commission.
Shanghai Shentong Metro (600834.SH) announced that, in order to implement the requirements of the State-owned Assets Supervision and Administration Commission of the State Council to deepen the reform of state-owned enterprises and focus on adjusting their main responsibilities and businesses, the company plans to transfer 100% of the equity of its wholly-owned subsidiary, Shanghai Metro Financial Leasing Co., Ltd. ("Financial Leasing Company"), to Shanghai Zhangjiang (Group) Co., Ltd. ("Zhangjiang Group") through an agreement transfer. The transaction price shall not be less than the audited net assets of the Financial Leasing Company as of September 30, 2025, which is 236 million yuan, and shall not be lower than the asset appraisal price filed with the Shanghai Municipal State-owned Assets Supervision and Administration Commission.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
